The EFFECTs were for the GNBT Oasis shares and the shares w warrants. I sure would like to see the preferred shares, myself.
That quantity of shares (250MM) hopefully won’t see the light of day until Generex is buying a large competitor in the future. They had to use a number to calculate the registration fees. But I’m quite sure Joe doesn’t intend to issue that many under the current circumstances (and at these prices)...
Generex Biotechnology Corp. (GNBT) Stock Research Links